Monthly HIV prevention pill enters phase three trials Monthly HIV prevention pill enters phase three trials, offering new hope in the global fight against HIV. The innovative tablet, known as MK-8527, may revolutionize pre-exposure prophylaxis (PrEP) by providing a full month of protection per dose. MK-8527 moves from promise to pivotal testing An HIV prevention … Continue reading Monthly HIV prevention pill enters phase three trials